These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6335134)

  • 21. [In vitro antibacterial activity and beta-lactamase stability of meropenem].
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):589-94. PubMed ID: 14756067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of in-vitro models: development of resistance.
    Seeberg AH; Wiedemann B
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():241-9. PubMed ID: 3884569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
    Matsumura N; Minami S; Mitsuhashi S
    J Antimicrob Chemother; 1997 Jan; 39(1):31-4. PubMed ID: 9044025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
    Villar HE; Jugo MB; Visser M; Hidalgo M; Hidalgo G; Maccallini GC
    Rev Esp Quimioter; 2014 Mar; 27(1):51-5. PubMed ID: 24676243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of cefpirome against beta-lactamase-inducible and stably derepressed Enterobacteriaceae.
    Binfiglio G; Stefani S; Nicoletti G
    Chemotherapy; 1994; 40(5):311-6. PubMed ID: 7956454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in-vitro activity of biapenem against enterobacteria with beta-lactamase-mediated antibiotic resistance.
    Chen HY; Livermore DM
    J Antimicrob Chemother; 1994 Mar; 33(3):453-64. PubMed ID: 8040111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
    Satake S; Hiraoka M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Mar; 33(3):398-9. PubMed ID: 2658787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbapenems: special properties contributing to their activity.
    Neu HC
    Am J Med; 1985 Jun; 78(6A):33-40. PubMed ID: 3873871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmid-mediated beta-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam.
    Gutmann L; Kitzis MD; Billot-Klein D; Goldstein F; Tran Van Nhieu G; Lu T; Carlet J; Collatz E; Williamson R
    Rev Infect Dis; 1988; 10(4):860-6. PubMed ID: 3055178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of CFE-2, a new plasmid-encoded AmpC β-lactamase from a clinical isolate of Citrobacter freundii.
    Chen CM; Huang M; Wu HJ; Guo MK; Wu LT
    Int J Antimicrob Agents; 2018 Sep; 52(3):421-424. PubMed ID: 29944954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of ceftazidime, cefepime and imipenem on 1,005 Pseudomonas aeruginosa clinical isolates either susceptible or resistant to beta-lactams.
    Bonfiglio G; Marchetti F
    Chemotherapy; 2000; 46(4):229-34. PubMed ID: 10859428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefoperazone against carbenicillin-resistant isolates of Pseudomonas aeruginosa: comparison with other newer cephalosporins and N-formimidoyl thienamycin.
    Chau PY; Ling J; Ng WS
    J Antimicrob Chemother; 1983 Oct; 12(4):337-45. PubMed ID: 6417100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.
    Jacobson KL; Cohen SH; Inciardi JF; King JH; Lippert WE; Iglesias T; VanCouwenberghe CJ
    Clin Infect Dis; 1995 Nov; 21(5):1107-13. PubMed ID: 8589129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipenem and cephem resistant Pseudomonas aeruginosa carrying plasmids coding for class B beta-lactamase.
    Minami S; Akama M; Araki H; Watanabe Y; Narita H; Iyobe S; Mitsuhashi S
    J Antimicrob Chemother; 1996 Mar; 37(3):433-44. PubMed ID: 9182100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
    Hashizume T; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
    [No Abstract]   [Full Text] [Related]  

  • 37. In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem.
    Pragai Z; Nagy E
    J Antimicrob Chemother; 1998 Dec; 42(6):821-4. PubMed ID: 10052909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substitution of aspartic acid-217 of Citrobacter freundii cephalosporinase and properties of the mutant enzymes.
    Tsukamoto K; Kikura R; Ohno R; Sawai T
    FEBS Lett; 1990 May; 264(2):211-4. PubMed ID: 1972682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration.
    Cao VT; Arlet G; Ericsson BM; Tammelin A; Courvalin P; Lambert T
    J Antimicrob Chemother; 2000 Dec; 46(6):895-900. PubMed ID: 11102406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxacillin-hydrolyzing beta-lactamase involved in resistance to imipenem in Acinetobacter baumannii.
    Hornstein M; Sautjeau-Rostoker C; Péduzzi J; Vessières A; Hong LT; Barthélémy M; Scavizzi M; Labia R
    FEMS Microbiol Lett; 1997 Aug; 153(2):333-9. PubMed ID: 9271860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.